Inhibrx Announces Participation in Upcoming Scientific Conferences
SAN DIEGO, Oct. 13, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates, today announced it will be presenting at the...
Covered in this story
What has happened since
- Inhibrx Biosciences Inc is up 11.5% since this was published, 9 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $INBX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Inhibrx Biosciences Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.